sTREM-1 as promising prognostic biomarker for acute-on-chronic liver failure and mortality in patients with acute decompensation of cirrhosis.

Song-Man YuHai LiGuo-Hong DengXian-Bo WangXin ZhengJin-Jun ChenZhong-Ji MengYu-Bao ZhengYan-Hang GaoZhi-Ping QianFeng LiuXiao-Bo LuYu ShiJia ShangRuo-Chan ChenYan Huang

Published in: World journal of gastroenterology (2024)

Serum sTREM-1 is a promising prognostic biomarker for ACLF development and mortality in patients with AD of cirrhosis.

Keyphrases

liver failure
hepatitis b virus
cardiovascular events
risk factors
coronary artery disease
drug induced
type diabetes
aortic dissection